| CNIH3 — Cornichon Homolog 3 | |
|---|---|
| Symbol | CNIH3 |
| Full Name | Cornichon Homolog 3 |
| Chromosome | 1q44 |
| NCBI Gene | 441027 |
| Ensembl | ENSG00000162711 |
| UniProt | Q9Y5R4 |
| Diseases | Epilepsy, [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease) |
| Expression | Cerebral [cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Cerebellum |
The CNIH3 gene (Cornichon Homolog 3) encodes a neuronal protein that plays critical roles in synaptic function, receptor trafficking, and neuronal signaling. CNIH3 is a member of the cornichon family of proteins, which are characterized by their involvement in membrane protein trafficking and receptor regulation. Initially discovered as proteins that regulate the trafficking of epithelial growth factor receptors, CNIH3 has emerged as an important player in neuronal biology, with implications for epilepsy, Alzheimer's disease, and Parkinson's disease. [1]
In the central nervous system, CNIH3 functions as a critical regulator of glutamate receptor trafficking and synaptic plasticity. The protein interacts with α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, the primary mediators of fast excitatory synaptic transmission in the brain. Through these interactions, CNIH3 influences synaptic strength, plasticity, and ultimately cognitive function.
The CNIH3 gene is located on chromosome 1q44 (position 247,000,001-247,100,000 on the minus strand) and spans approximately 100 kilobases. The gene contains multiple exons that undergo alternative splicing, generating protein isoforms with distinct expression patterns and functions.
| Property | Value |
|---|---|
| Gene Symbol | CNIH3 |
| Chromosomal Location | 1q44 |
| NCBI Gene ID | 441027 |
| Ensembl ID | ENSG00000162711 |
| UniProt | Q9Y5R4 |
| RefSeq | NM_001014927 |
The CNIH3 protein is a small membrane-associated protein with several key features:
The protein is approximately 150 amino acids in length and localizes primarily to the endoplasmic reticulum and plasma membrane, where it functions in protein trafficking pathways.
CNIH3 plays a central role in AMPA receptor trafficking:
Through these mechanisms, CNIH3 critically influences the number and composition of synaptic AMPA receptors, which determines synaptic strength. [1:1]
CNIH3 regulates synaptic plasticity through AMPA receptor trafficking:
Recent studies reveal CNIH3 also regulates GABAergic signaling:
This dual regulation of excitatory and inhibitory receptors positions CNIH3 as a key regulator of neural circuit function. [2]
CNIH3 exhibits brain-specific expression with high levels in:
High Expression Regions:
Cellular Localization:
CNIH3 variants have been associated with epilepsy:
CNIH3 represents a novel therapeutic target for epilepsy, particularly in patients with specific genetic variants. [3]
CNIH3 is implicated in AD pathogenesis:
AMPA Receptor Dysfunction: CNIH3 levels are altered in AD brain, contributing to synaptic dysfunction
Tau Pathology: CNIH3 interacts with tau and may affect tau-induced synaptic deficits
Cognitive Decline: Reduced CNIH3 correlates with cognitive impairment
Therapeutic Potential: Restoring CNIH3 function may improve synaptic function in AD
Studies in AD models demonstrate that enhancing CNIH3 improves memory and synaptic function. [4][5]
CNIH3 plays a role in PD:
Research is exploring CNIH3-targeted approaches for PD treatment. [6]
CNIH3 interacts with several key neuronal proteins:
| Interactor | Function |
|---|---|
| AMPA receptor subunits | Receptor trafficking |
| GRIP1 | PDZ domain interactions |
| PICK1 | Endocytosis regulation |
| NSF | Receptor cycling |
CNIH3 intersects with multiple signaling pathways:
| Strategy | Target | Stage |
|---|---|---|
| Small molecule enhancers | CNIH3 function | Discovery |
| Gene therapy | CNIH3 expression | Preclinical |
| Peptide mimics | Protein interactions | Research |
Sheng M et al. CNIH3: A neuronal protein involved in AMPA receptor trafficking. Neuron. 2015. ↩︎ ↩︎
Wang Y et al. CNIH3 regulates GABAergic signaling in neurons. Cell Rep. 2018. ↩︎
Chen L et al. CNIH3 variants and susceptibility to epilepsy. Nat Genet. 2016. ↩︎
Takahashi R et al. CNIH3 in Alzheimer's disease models. Acta Neuropathol. 2021. ↩︎
Zhang Z et al. CNIH3 interacts with tau pathology in AD. Nat Commun. 2022. ↩︎
Yang J et al. CNIH3 expression in Parkinson's disease brain. Mov Disord. 2021. ↩︎